In this study, David Skibinski and colleagues from Merck Singapore developed a method to use Chipcytometry for detection and phenotyping of circulating tumor cells in patient blood.
In this study, David Skibinski and colleagues from Merck Singapore developed a method to use Chipcytometry for detection and phenotyping of circulating tumor cells in patient blood.